# DESCRIPTION

## BACKGROUND OF THE INVENTION

- describe E. coli O157:H7 infection and its effects

## SUMMARY OF THE INVENTION

- identify immunogenic proteins using IVIAT
- identify immunogenic proteins in cattle using PELS
- describe isolated nucleic acid molecules
- describe vectors and cells including isolated nucleic acid molecules
- describe method of producing recombinant polypeptides
- describe recombinant polypeptides
- describe method for identifying compounds that decrease pathogenic factor expression
- describe method for identifying compounds that bind polypeptides
- describe method of treating pathogenic infection
- describe vaccine compositions
- describe diagnostic compositions and methods

## DETAILED DESCRIPTION

- identify immunogenic proteins

### Example 1

- motivate E. coli antigens identification
- describe IVIAT technique
- outline materials and methods
- detail bacterial strains, plasmids, and growth conditions
- describe patient and control sera
- outline assessment of reactivity of pooled sera with immunogenic O157 proteins
- describe construction of inducible E. coli O157:H7 genomic DNA expression library
- outline screening of expression library and identification of clones expressing immunogenic O157 proteins
- motivate IVIAT protocol
- describe adsorption of pooled HUS-convalescent sera
- summarize screening of O157 genomic expression library
- identify IVI-proteins included in O157 virulence
- categorize IVI-proteins expressed from O157 backbone
- describe functional classes of IVI-proteins
- summarize IVI-proteins expressed from O-islands
- introduce ivi-proteins
- describe phage-related proteins
- identify non-phage ivi-proteins
- discuss ivi-proteins expressed from pO157
- analyze reactivity of ivi-proteins with HUS-convalescent serum
- conclude ivi-proteins and their potential applications

### Example 2

- motivate E. coli vaccination in cattle
- limitations of traditional methodologies for identifying immunogenic microbial proteins
- introduce PELS technique for rapid identification of microbial immunomes
- describe materials and methods for PELS
- outline construction of inducible E. coli genomic DNA expression library
- describe expression and preparation of cell-lysate and pellet fractions for immunoaffinity capture
- describe GeLC-MS/MS protocol
- outline in-gel digestion and peptide extraction
- detail mass spectrometry analysis
- explain peptide identification and filtering
- describe generation and evaluation of hyperimmune sera
- summarize PELS-identified O157 immunoproteome

### Example 3

- identify immunogenic proteins from pathogens

### Example 4

- evaluate proteins as vaccines for cattle

### Example 5

- isolate additional coding sequences of virulence factors
- use nucleotide sequences as probes to screen a recombinant DNA library
- design specific oligonucleotide probes for gene isolation
- use PCR “RACE” technique to isolate full-length cDNA
- confirm sequence's relatedness to a pathogenicity polypeptide
- produce polypeptides of the invention by transformation of a suitable host cell
- express and purify polypeptides using various expression systems
- generate antibodies against polypeptides of the invention
- screen compounds to identify those that reduce the virulence of a pathogen
- use polypeptides or nucleic acid sequences to identify compounds that inhibit pathogenicity
- develop pharmaceutical therapeutics and vaccines using identified compounds

